Companies › APLM

APOLLOMICS INC (APLM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001944885 · EDGAR filings · Updated 2026-07-24

APOLLOMICS INC (APLM) has reported institutional ownership of 111.0%, with 13 institutional managers holding positions valued at $5.96M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Initial insider ownership filed (Form 3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Foreign issuer report (6-K) filed
• 2026-07-14 — Foreign issuer report (6-K) filed
• 2026-06-24 — Foreign issuer report (6-K) filed
• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-16 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, APOLLOMICS INC has 13 institutional holders and institutional ownership of 111.0%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

NERVGEN PHARMA CORP (NGEN) · HEARTBEAM INC (BEAT) · INMUNE BIO INC (INMB) · CYPHERPUNK TECHNOLOGIES INC (CYPH) · Scilex Holding Co (SCLX) · Natural Alternatives International Inc (NAII)